A*STAR Bioprocessing Technology Institute (A*STAR BTI)

A new ‘liquid lipid’ approach that penetrates the nose’s mucus barrier could lead to needle-free, nasal spray-based mRNA vaccines.

A*STAR researchers discover how subtle changes to a packaging component of mRNA vaccines can boost their efficacy and safety.

Combining biology and analytical chemistry, Yu Hui Kang is developing cell infusions to fight cancer and autoimmune diseases.

Integrating molecular insights from several omics profiling approaches, A*STAR research initiatives are deepening our understanding of human physiology and unearthing new diagnostic and therapeutic opportunities.

New insights on heat and acidity’s role in monoclonal antibody clumping pave the way for improved biotherapeutics production methods.

A study on how animal meats and their plant-based alternatives are digested uncover key nutritional differences with implications for future food innovation.

Combining engineering precision and data-driven insights, Charmaine Chia builds miniature technologies that unlock groundbreaking solutions for biotechnology.

Cell and gene therapies are driving the next revolution in medicine, combining the best of biology with game-changing technologies from A*STAR researchers and partners.

A*STAR researchers developed specially designed nanocomplexes that effectively target and kill cancer cells, including those resistant to traditional treatments.

Taking lessons from an eye-opening stint in industry, Sean Chia is tackling the challenges of biotherapeutics manufacturing to help bring game-changing antibody treatments to more patients.

A*STAR researchers tackle the challenge of creating therapeutic antibodies that effectively kill tumours and are also easily scalable in manufacturing settings.

Researchers develop an analytical technique to combat food fraud by accurately profiling and differentiating meat samples based on their unique glycan profiles.